X4 Pharmaceuticals (XFOR) Short-term Investments (2017 - 2019)

X4 Pharmaceuticals (XFOR) has reported Short-term Investments for 3 consecutive years, with $3.2 million the latest figure, recorded in Q2 2019.

• For the quarter ending Q2 2019, Short-term Investments rose 6101.96% year-over-year to $3.2 million; the trailing twelve-month figure through Jun 2019 stood at $3.2 million (up 6101.96% YoY), and the FY2018 full-year result was $101000.0, changed N/A from the prior year.
• Short-term Investments advanced to $3.2 million in Q2 2019 per XFOR's latest filing, from $101000.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $8.4 million in Q2 2017 and bottomed at $51000.0 in Q1 2018.
• Historically, Short-term Investments has averaged $2.3 million across 3 years, with a median of $848000.0 in 2017.
• The sharpest annual moves came in 2018 and 2019: Short-term Investments slumped 99.39% in 2018, then jumped 6101.96% in 2019.
• Over 3 years, Short-term Investments stood at $5.1 million in 2017, then slumped by 98.03% to $101000.0 in 2018, then soared by 3031.68% to $3.2 million in 2019.
• According to Business Quant data, Short-term Investments over the past three periods registered $3.2 million, $101000.0, and $51000.0 for Q2 2019, Q4 2018, and Q3 2018 respectively.